Haywood Reiterates $80 Price Target On Trulieve After Harvest Health Purchase

On October 1st, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition of Harvest Health. Harvest shareholders received 0.1170 shares of Trulieve for each subordinate voting share held.

A number of analysts raised their 12-month price targets off the back of the acquisition. This brought the average 12-month price target up to C$84.80, or a 137% upside. There are 17 analysts covering the stock, with 5 analysts having strong buy ratings and the other 12 have buy ratings. The street high sits at C$132 from Stifel-GMP while the lowest comes in at C$54.

In Haywood Capital Market’s note, they reiterated their C$80 price target and buy rating on Trulieve Cannabis saying that this establishes Trulieve as one of the top tier-1 MSO’s. They add, “The acquisition was completed within 5 months which is an impressive accomplishment in our view.”

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

With this acquisition, Trulieve grows its addressable market from 6 to 11, gaining 5 new markets and going deeper in 4 markets Haywood says. They believe that margin compression will come with the acquisition but comment that the additional markets are a worthy trade-off “for its long-term growth trajectory while also being able to maintain healthy margins.”

Below you can see Haywood’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

This Gold Giant Was a Mess. Now It’s Back! | Barrick Mining Q3 2026 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Canaccord Raises Price Target On Teranga Gold Following Pre-Feasibility Study

Last night, Teranga Gold Corp (TSX: TGZ) announced the results of the Sabodala-Massawa Gold Complex’s...

Monday, July 27, 2020, 06:43:23 PM

CN Rail: BMO Anticipates Continued Strong Earnings

Canadian National Railway (TSX: CNR) last week released its third-quarter financial and operating results. The...

Thursday, November 3, 2022, 04:38:00 PM

Ascot Resources Sees BMO Lower Target To $1.25 Following Construction Delays

On June 23rd, Ascot Resources (TSX: AOT) provided investors with a series of updates. In...

Sunday, June 26, 2022, 11:07:00 AM

NG Energy: Canaccord Initiates Coverage With $1.40 Price Target

Last week Canaccord Genuity Capital Markets’ initiated coverage on NG Energy (TSXV: GASX) with a...

Friday, July 22, 2022, 12:37:00 PM

BMO Lowers Maple Leaf Foods’ Earnings Estimates On Expected Headwinds

Maple Leaf Foods (TSX: MFI) is expected to report its second-quarter financial results on August...

Saturday, July 9, 2022, 03:17:00 PM